Seminars in Arthritis and Rheumatism
Volume 40, Issue 1 , Pages 32-52 , August 2010

Magnetic Resonance Imaging and Brain Histopathology in Neuropsychiatric Systemic Lupus Erythematosus

  • Wilmer L. Sibbitt Jr, MD

      Affiliations

    • Professor of Rheumatology and Neurology, The University of New Mexico Heath Sciences Center, Albuquerque, NM
    • Corresponding Author InformationAddress reprint requests to: Wilmer L. Sibbitt Jr, MD, Department of Internal Medicine, Division of Clinical Immunology and Rheumatic Diseases, MSC 10 5550, 5th FL ACC, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
    • ,
  • William M. Brooks, PhD

      Affiliations

    • Director, Hoglund Brain Imaging University of Kansas Health Sciences Center, Kansas City, KS
    • ,
  • Mario Kornfeld, MD

      Affiliations

    • Professor of Neuropathology, The University of New Mexico Heath Sciences Center, Albuquerque, NM
    • ,
  • Blaine L. Hart, MD

      Affiliations

    • Professor of Radiology, The University of New Mexico, Albuquerque, NM
    • ,
  • Arthur D. Bankhurst, MD

      Affiliations

    • Professor of Rheumatology, The University of New Mexico Heath Sciences Center, Albuquerque, NM
    • ,
  • Carlos A. Roldan, MD

      Affiliations

    • Professor of Cardiology, The University of New Mexico Heath Sciences Center, Albuquerque, NM

References 

  1. Hanly JG, Urowitz MB, Su L, Sanchez-Guerrero J, Bae SC, Gordon C, et al. Systemic Lupus International Collaborating Clinics Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study. Arthritis Rheum. 2008;59:721–729
  2. Hanly JG. The neuropsychiatric SLE SLICC inception cohort study. Lupus. 2008;17:1059–1063
  3. McCune WJ, MacGuire A, Aisen A, Gebarski S. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum. 1988;31:159–166
  4. Brooks WM, Sabet A, Sibbitt WL, Barker PB, van Zijl PCM, Duyn JH, et al. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. J Rheum. 1997;24:2323–2329
  5. Sundgren PC, Jennings J, Attwood JT, Nan B, Gebarski S, McCune WJ, et al. MRI and 2D-CSI MR spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus. Neuroradiology. 2005;47:576–585
  6. Friedman SD, Stidley C, Brooks WM, Hart BL, Sibbitt WL. Brain injury and neurometabolic abnormalities in systemic lupus erythematosus. Radiology. 1998;209:79-8
  7. Sibbitt WL, Haseler L, Griffey RH, Hart B, Sibbitt RR, Matwiyoff N. Analysis of cerebral structural changes in systemic lupus erythematosus by MR proton spectroscopy. Am J Neuroradiol. 1994;15:923–928
  8. Sibbitt WL, Brooks WM, Haseler LJ, Griffey RH, Frank LM, Hart BL, et al. Spin-spin relaxation of brain tissues in systemic lupus erythematosus. Arthritis Rheum. 1995;38:810–818
  9. Sibbitt WL, Haseler LJ, Griffey RR, Friedman SD, Brooks WM. Neurometabolism of active neuropsychiatric lupus determined by proton MR spectroscopy. AJNR Am J Neuroradiol. 1997;18:1271–1277
  10. Sibbitt WL, Sibbitt RR, Brooks WM. Neuroimaging in neuropsychiatric SLE. Arthritis Rheum. 1999;42:2026–2038
  11. Sabet A, Sibbitt WL, Stidley CA, Danska J, Brooks WM. Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus. Stroke. 1998;29:2254–2260
  12. Ishikawa O, Ohnishi K, Miyachi Y, Ishizaka H. Cerebral lesions in systemic lupus erythematosus detected by magnetic resonance imaging (Relationship to anticardiolipin antibody). J Rheumatol. 1994;21:87–90
  13. Jarek M, West SG, Baker MR, Rak KM. Magnetic resonance imaging in systemic lupus erythematotus patients without a history of neuropsychiatric lupus erythematosus. Arthritis Rheum. 1994;37:1609–1613
  14. Sibbitt WL, Sibbitt RR, Griffey RH, Eckel CG, Bankhurst AD. Magnetic resonance and CT imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis. 1989;48:1014–1022
  15. Brooks WM, Jung RE, Ford CC, Greinel EJ, Sibbitt WL, et al. Relationship between neurometabolite derangement and neurocognitive dysfunction in systemic lupus erythematosus. J Rheum. 1999;26:81–85
  16. Kozora E, West SG, Kotzin BL, Julian L, Porter S, Bigler E. Magnetic resonance imaging abnormalities and cognitive defects in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum. 1998;41:41–47
  17. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. 1982 Revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271–1277
  18. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725–1726
  19. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH Committee on Prognosis Studies in SLE. Derivation of the SLEDAI (A disease activity index for lupus patients). Arthritis Rheum. 1992;35:630–640
  20. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996;39:363–369
  21. Sibbitt WL, Schmidt PJ, Hart BL, Brooks WM. Fluid Attenuated Inversion Recovery (FLAIR) imaging in neuropsychiatric systemic lupus erythematosus. J Rheumatol. 2003;30:1983–1989
  22. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42:599–608
  23. Walecki J, Sierakowski S, Lewszuk A, Sulik A, Tarasow E, Lebkowska U. MR in neurological syndromes of connective tissue diseases. Med Sci Monit. 2002;8:MT105-11
  24. Moritani T, Shrier DA, Numaguchi Y, Takahashi C, Yano T, Nakai K, et al. Diffusion-weighted echo-planar MR imaging of CNS involvement in systemic lupus erythematosus. Acad Radiol. 2001;8:741–753
  25. Bosma GP, Huizinga TW, Mooijaart SP, Van Buchem MA. Abnormal brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus. AJNR Am J Neuroradiol. 2003;24:850–854
  26. Funata N. Cerebral vascular changes in systemic lupus erythematosus. Bull Tokyo Med Dent Univ. 1979;26:91–112
  27. Ellison D, Gatter K, Heryet A, Esiri M. Intramural platelet deposition in cerebral vasculopathy of systemic lupus erythematosus. J Clin Pathol. 1993;46:37–40
  28. Shiozawa S, Kuroki Y, Kim M, Hirohata S, Ogino T. Interferon-alpha in lupus psychosis. Arthritis Rheum. 1992;35:417–422
  29. Johnson R, Richardson EP. The neurological manifestations of systemic lupus erythematosus (A clinical-pathological study of 24 cases and review of the literature). Medicine. 1968;47:337–369
  30. Ellis SG, Verity MA. Central nervous systemic involvement in systemic lupus erythematosus: a review of neuropathological findings in 57 cases, 1955-1977. Semin Arthritis Rheum. 1979;8:212–221
  31. Hanly JG, Walsh N, Sangalang V. Brain pathology in systemic lupus erythematosus. J Rheumatol. 1992;19:732–741
  32. Devinsky O, Petito CK, Alonso DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol. 1988;23:380–384
  33. Sakaki T, Morimoto T, Utsumi S. Cerebral transmural angiitis and ruptured cerebral aneurysms in patients with systemic lupus erythematosus. Neurochirurgia (Stuttg). 1990;33:132–135
  34. Hammad A, Tsukada Y, Torre N. Cerebral occlusive vasculopathy in systemic lupus erythematosus and speculation on the part played by complement. Ann Rheumatic Dis. 1992;51:550–552
  35. Hopkins P, Belmont HM, Buyon J, Philips M, Weissman G, Abramson SB. Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis. Arthritis Rheum. 1988;31:632–641
  36. Belmont HM, Abramson SB, Lie JT. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus: interactions of inflammatory cells and activated endothelium. Arthritis Rheum. 1996;39:9–22
  37. Falk RJ, Dalmasso AP, Kim Y, Lam S, Michael A. Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus. N Engl J Med. 1985;312:1594–1599
  38. Mitsias P, Levine SR. Large cerebral vessel occlusive disease in systemic lupus erythematosus. Neurology. 1994;44:385–393
  39. Hughson MD, McCarty GA, Sholer CM, Brumback RA. Thrombotic cerebral arteriopathy in patients with the antiphospholipid syndrome. Mod Pathol. 1993;6:644–653
  40. Levine SR, Deegan MJ, Futrell N, Welch KM. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology. 1990;40:1181–1189
  41. Bruyn GA. Controversies in lupus: nervous system involvement. Ann Rheum Dis. 1995;54:159–167
  42. Shintaku M, Matsumoto R. Disseminated perivenous necrotizing encephalomyelitis in systemic lupus erythematosus: report of an autopsy case. Acta Neuropathol (Berl). 1998;95:313–317
  43. Roldan CA, Gelgand EA, Qualls CR, Sibbitt WL. Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus. Am J Cardiol. 2005;95:1441–1447
  44. Roldan CA, Gelgand EA, Qualls CR, Sibbitt WL. Valvular heart disease is associated with non-focal neuropsychiatric systemic lupus erythematosus. J Clin Rheumatol. 2006;12:3–10
  45. Roldan CA, Gelgand EA, Qualls CR, Sibbitt WL. Valvular heart disease by transthoracic echocardiography is associated with focal brain injury and central neuropsychiatric systemic lupus erythematosus. Cardiology. 2007;108:331–337
  46. Roldan CA, Qualls CR, Sopko KS, Sibbitt WL. Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study. J Rheumatol. 2008;35:224–229
  47. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med. 2001;7:1189–1193
  48. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994;330:613–622
  49. Kowal C, DeGiorgio LA, Nakaoka T, Hetherington H, Huerta PT, Diamond B, et al. Cognition and immunity; antibody impairs memory. Immunity. 2004;21:179–188
  50. Emmer BJ, Steens SC, Steup-Beekman GM, van der Grond J, Admiraal-Behloul F, Olofsen H, et al. Detection of change in CNS involvement in neuropsychiatric SLE: a magnetization transfer study. J Magn Reson Imaging. 2006;24:812–816
  51. Steens SC, Steup-Beekman GM, Bosma GP, Admiraal-Behloul F, Olofsen H, Doornbos J, et al. The effect of corticosteroid medication on quantitative MR parameters of the brain. AJNR Am J Neuroradiol. 2005;26:2475–2480
  52. Bosma GP, Steens SC, Petropoulos H, Admiraal-Behloul F, van den Haak A, Doornbos J, et al. Multisequence magnetic resonance imaging study of neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 2004;50:3195–3202
  53. Steens SC, Admiraal-Behloul F, Bosma GP, Steup-Beekman GM, Olofsen H, Le Cessie S, et al. Selective gray matter damage in neuropsychiatric lupus. Arthritis Rheum. 2004;50:2877–2881
  54. Steens SC, Bosma GP, Steup-Beekman GM, le Cessie S, Huizinga TW, van Buchem MA. Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus. Arthritis Res Ther. 2006;8:R38
  55. Dehmeshki J, Van Buchem MA, Bosma GP, Huizinga TW, Tofts PS. Systemic lupus erythematosus: diagnostic application of magnetization transfer ratio histograms in patients with neuropsychiatric symptoms—initial results. Radiology. 2002;222:722–728
  56. Steens SC, Bosma GP, ten Cate R, Doornbos J, Kros JM, Laan LA, et al. A neuroimaging follow up study of a patient with juvenile central nervous system systemic lupus erythematosus. Ann Rheum Dis. 2003;62:583–586
  57. Sanna G, Piga M, Terryberry JW, Peltz MT, Giagheddu S, Satta L, et al. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus. 2000;9:573–583
  58. Braffman BH, Zimmerman RA, Trojanowski JQ, Gonatas NK, Hickey WF, Schlaepfer WW. Brain MR: pathologic correlation with gross and histopathology. 1. Lacunar infarction and Virchow-Robin spaces. AJR Am J Roentgenol. 1988;151:551–558
  59. Braffman BH, Zimmerman RA, Trojanowski JQ, Gonatas NK, Hickey WF, Schlaepfer WW. Brain MR: pathologic correlation with gross and histopathology. 2. Hyperintense white-matter foci in the elderly. AJR Am J Roentgenol. 1988;151:559–566
  60. Grossman RI, Braffman BH, Brorson JR, Goldberg HI, Silberberg DH, Gonzalez-Scarano F. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. Radiology. 1988;169:117–122
  61. Man'kovskii NB. Diencephalic pathology in the clinical picture of certain collagenoses in young and middle aged patients. Gerontol Clin. 1969;11:231–238
  62. Anderson JR. Intracerebral calcification in a case of systemic lupus erythematosus with neurological manifestations. Neuropathol Appl Neurobiol. 1981;7:161–166
  63. Nagaoka S, Matsunaga K, Chiba J, Ishigatsubo Y, Tani K. Five cases of systemic lupus erythematosus with intracranial calcification. Rinsho Shinkeigaku. 1982;22:635–643
  64. Yokota S, Mori T, Kosuge K, Takahashi K, Nishiyama Y, Uechi M, et al. Basal ganglia calcification in two children with systemic lupus erythematosus and neuropsychiatric manifestations. Ryumachi. 1985;25:115–122
  65. Stuart BM, Gregson NA. Cerebral calcification in a patient with systemic lupus erythematosus and a monoclonal IgG reactive with glial fibrillary acidic protein. Br J Rheumatol. 1998;37:1355–1357
  66. Shimojima Y, Gono T, Hoshi K, Yamamoto K, Yoshida K, Matsuda M, et al. Neuropsychiatric systemic lupus erythematosus associated with anti-phospholipid syndrome, showing massive intracranial calcifications. No To Shinkei. 2003;55:885–888
  67. Cañas CA, Tobón GJ. Multiple brain calcifications in a patient with systemic lupus erythematosus. Clin Rheumatol. 2008;27(Suppl 2):S63–S65
  68. Viswanathan A, Chabriat H. Cerebral microhemorrhage. Stroke. 2006;37:550–555
  69. Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn Reson Med. 2004;52:612–618

 This work was supported by research grants from the US National Institutes of Health including R01 HL077422-01-A3 to Dr. Roldan, R01 NS039123 to Dr. Brooks, and R01 NS035708 to Dr. Sibbitt.

PII: S0049-0172(09)00100-0

doi: 10.1016/j.semarthrit.2009.08.005

Seminars in Arthritis and Rheumatism
Volume 40, Issue 1 , Pages 32-52 , August 2010

Article Tools

* Image Usage & Resolution